PAREXEL Forms Alliance With Catalent For Clinical Trial Supply Chain Solution

PAREXEL International Corporation, a biopharmaceutical services provider, has established an alliance with Catalent Pharma Solutions, a provider of development solutions and drug delivery technologies.

PAREXEL and Catalent have aligned their core competencies to provide a fully integrated, clinical trial material supply chain solution. This solution will help streamline the clinical supply process and reduce timelines, while enhancing patient safety and improving service quality, said Catalent.

Combining PAREXEL's clinical trial management services and global clinical logistics capabilities with Catalent's manufacturing, packaging and labeling solutions, the alliance can help ensure that clinical trial materials are in the right place at the right time, said PARAXEL.

"We have seen demand from clients for a robust solution that can address the challenge of efficiently managing clinical trial material logistics across large numbers of global sites" commented Kurt Norris, corporate vice president and worldwide head of clinical logistics services, PAREXEL. "In establishing this alliance with Catalent, we are uniquely positioned to help companies reach critical development milestones sooner through more efficient manufacturing, packaging and delivery of clinical trial material supplies."

"As clinical trials become more complex, we feel it is imperative to help sponsors devise supply strategies and organize consistent manufacturing, packaging, and delivery of trial-related supplies to locations around the world," stated Gerry Hepburn, COO and vice president/general manager of clinical supply services at Catalent. "PAREXEL, with its extensive track record in clinical development and clinical trial material supply chain expertise, is the ideal partner for Catalent in this alliance, which will enable our customers to compete more effectively in the global marketplace."